The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.
about
Efficacy and safety of ablation for patients with non-paroxysmal atrial fibrillationExercise-based cardiac rehabilitation for adults with atrial fibrillationSymptoms In Atrial Fibrillation: A Contemporary Review And Future DirectionsCost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs.Rate-control or rhythm-control: where do we stand?The burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy?Wall-motion based analysis of global and regional left atrial mechanics.Symptom Clusters in Adults With Chronic Atrial Fibrillation.Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation.The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life.An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease.U22 protocol as measure of symptomatic improvement after catheter ablation of atrial fibrillationDifferences in quality of life, anxiety and depression in patients with paroxysmal atrial fibrillation and common forms of atrioventricular reentry supraventricular tachycardias.Exercise-based cardiac rehabilitation for adults with atrial fibrillation.Symptomatic improvement after catheter ablation of supraventricular tachycardia measured by the arrhythmia-specific questionnaire U22.Atrial fibrillation: the newest frontier in arrhythmia management.Quality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and Wellness Survey.Depression in atrial fibrillation in the general population.Internal medicine physicians' perceptions regarding rate versus rhythm control for atrial fibrillation.Role of amiodarone in the era of the implantable cardioverter defibrillator.Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation.One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.Costs and clinical consequences of suboptimal atrial fibrillation management.Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL).Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.Incident atrial fibrillation in the emergency department in Ontario: a population-based retrospective cohort study of follow-up careEffect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome.Quality of life in older patients with atrial fibrillation.Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.Radiofrequency Catheter Ablation Improves the Quality of Life Measured with a Short Form-36 Questionnaire in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillationThe future of atrial fibrillation therapy.Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials.The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol.
P2860
Q24186195-2A0038B2-27DD-4942-900C-B8B0C9D78B8DQ24195079-3851C791-5DDF-42A8-8BCB-28B4F650B709Q28070025-EB15523E-2E8D-4B05-B865-013961C95619Q28077393-ADDD9714-6922-422A-9FE8-83EEDA247044Q28200383-B10BDC77-9FFF-417B-8CCB-A685B4A19ED4Q30350063-CD7944D5-2DBE-48F6-AE19-72D4F9A4B252Q30405273-5B9D2D7B-E284-4BD0-B4DE-FE1617D6BE67Q33167198-0F2BF662-FDF2-4EB9-AFDE-3088678CD882Q33585592-3B7AD5B6-C163-4DED-A71B-EEB3F9643F21Q33585619-14016374-2321-4CC6-86E2-086B1D61ED47Q33806739-26EB7C86-4D67-4242-A696-981A89F7B1D7Q33811334-CB6192C7-1592-4080-BF75-9E70C0DBD332Q33811339-4A155F7C-0272-4BCB-8EAB-7C26794C2683Q34169705-21F3B0FB-0DC4-4A49-9BD4-D9AF7EF0534EQ34311156-C6D02FCA-66B9-4041-BBD3-22B9B9919B39Q34441457-61008D33-706A-4BC9-ABDF-121D0A19AFB7Q34550885-4FFC79C9-B37C-4288-8038-C9872A167D58Q34577363-C06EBC67-2B1C-4C82-A8A3-F5A6EFCF7D91Q34714741-3FC84B53-7389-41F0-954E-6426B33876EDQ34949056-4634C3CF-1D9C-44AE-BF81-DBD995AF6CFDQ35063678-48888FC8-F77C-4116-A0B9-F3EFE5D1A789Q35180923-5C645940-6FC5-4C5B-9964-2E6EA6C12ADDQ35209698-90991A2A-4EED-4001-B361-8A387AE25CB7Q35526930-8EACCA7B-7CC9-4CA0-A151-9BA77F59DB4AQ35677114-ACF397E6-1292-4B0E-A74B-044A2A44F026Q35772348-BCF5C86E-4630-44D5-875E-0F6114ED13BAQ35782224-ED116D69-9B53-45D9-9C87-6ED7D8F4784CQ35885128-C0A779DE-162D-4574-805E-3C4509380D35Q35903784-5514490D-F730-4576-819C-F795FFB12A96Q35919294-083FB117-A80C-4FC1-B381-B0B55E297BF2Q35941124-5D0C8EB8-F19B-4FB2-ADD7-931A4E9048CDQ36045899-1FAFD566-94A3-4B0E-B2BA-55627028DA43Q36053853-D6E894A1-63CE-4A65-B4C7-AD3C0167A6A9Q36077784-70842376-50A5-40B9-AC5C-BABAE460B91CQ36108848-8CF66C7E-CC9D-4965-8A15-0290D2A429E3Q36147009-108E109C-8B2F-420A-9D8A-DC77355E3C7AQ36407198-C04ECAFD-F24F-4793-B192-0CE388BF0A42Q36580659-A5CEF731-D97A-4C04-8352-E3089D560FE2Q36584622-673BD3A4-F4DF-497F-9D62-5C7C53DCC24DQ36650126-F7FBACFD-7D07-4A01-B6AD-9A5C6B4432D2
P2860
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The impairment of health-relat ...... nt of investigational therapy.
@en
The impairment of health-relat ...... nt of investigational therapy.
@nl
type
label
The impairment of health-relat ...... nt of investigational therapy.
@en
The impairment of health-relat ...... nt of investigational therapy.
@nl
prefLabel
The impairment of health-relat ...... nt of investigational therapy.
@en
The impairment of health-relat ...... nt of investigational therapy.
@nl
P2093
P921
P1476
The impairment of health-relat ...... nt of investigational therapy.
@en
P2093
Luderitz B
Paquette M
P304
P356
10.1016/S0735-1097(00)00886-X
P407
P577
2000-10-01T00:00:00Z